These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7781523)
1. [Restriction enzyme mismatch polymerase chain reaction in the demonstration of Ki-ras-oncogene mutation in carcinoma of the pancreas]. Heller T; Trautmann B; Zöller-Utz I; König HJ; Liebe S; Ell C; Löhr M Dtsch Med Wochenschr; 1995 Jun; 120(23):826-30. PubMed ID: 7781523 [TBL] [Abstract][Full Text] [Related]
2. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]. Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522 [TBL] [Abstract][Full Text] [Related]
3. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma. Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168 [TBL] [Abstract][Full Text] [Related]
4. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
5. [Ki-ras mutation--a specific and sensitive tumor marker for carcinoma of the pancreas?]. Schmid RM; Adler G Dtsch Med Wochenschr; 1995 Jun; 120(23):830-3. PubMed ID: 7781524 [No Abstract] [Full Text] [Related]
6. [Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma]. Krechler T; Janda J; Dufek V; Kaláb M; Pesková M; Dorazilová V Vnitr Lek; 1997 Oct; 43(10):678-81. PubMed ID: 9601883 [TBL] [Abstract][Full Text] [Related]
7. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme]. Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964 [TBL] [Abstract][Full Text] [Related]
8. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. Cui Q; Wang Z; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165 [TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Demeure MJ; Doffek KM; Komorowski RA; Wilson SD Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933 [TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989 [TBL] [Abstract][Full Text] [Related]
11. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. Minamoto T; Mai M; Ronai Z Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118 [TBL] [Abstract][Full Text] [Related]
12. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma]. Cui Q; Wang Z; Chen J; Liu T Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596 [TBL] [Abstract][Full Text] [Related]
13. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases. Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044 [TBL] [Abstract][Full Text] [Related]
14. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039 [TBL] [Abstract][Full Text] [Related]
15. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
16. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas. Mueller J; Gansauge S; Mattfeldt T Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623 [TBL] [Abstract][Full Text] [Related]
18. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma. Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874 [TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941 [TBL] [Abstract][Full Text] [Related]
20. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma]. Zhang Y; Ji SR; Feng DX; Ji J; Han TQ Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]